5 things to watch on the ASX 200 on Monday

The ASX 200 looks set to start the week on a positive note.

On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week on a subdued note. The benchmark index fell 0.1% to 7,049.4 points.

Will the market be able to bounce back from this on Monday? Here are five things to watch:

Man in a wheelchair at a desk, checking his computer.

Image source: Getty Images

ASX 200 expected to rebound

The Australian share market looks set to open the week higher following a relatively positive finish on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 28 points or 0.4% higher on Monday. In the United States, the Dow Jones was up a fraction, the S&P 500 rose 0.1%, and the NASDAQ also rose 0.1%.

Oil prices jump

ASX 200 energy shares including Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) should start the week strongly after oil prices jumped on Friday night. According to Bloomberg, the WTI crude oil price was up 4% to US$75.84 a barrel and the Brent crude oil price was up 4.1% to US$80.61 a barrel. Analysts appear to believe the recent selloff was overdone.

Pro Medicus AGM

Pro Medicus Limited (ASX: PME) shares will be in focus on Monday when the health imaging technology company holds its annual general meeting. The high-flying tech stock could provide the market with an update on its first-quarter performance at the event.

Neuren rated as a buy

Neuren Pharmaceuticals Ltd (ASX: NEU) shares are in the buy according to Bell Potter. Its analysts have responded to the pharmaceutical company's latest update by retaining their buy rating and $17.50 price target. The broker said: "Neuren's commercial partner Acadia is guiding to ~US$175m in DAYBUE sales for CY23 after only 8 months on the US market. This impressive launch will translate into large sums of ongoing royalties and one-off sales milestones to NEU."

Gold price edges lower

ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) could have a soft start to the week after the gold price edged lower on Friday. According to CNBC, the spot gold price was down 0.2% to US$1,983.5 an ounce. This may have been driven by profit-taking after strong gains in previous sessions. Gold rose 2.3% last week.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Person holding Australian dollar notes, symbolising dividends.
Dividend Investing

75% of my dividends come from these 4 ASX shares (and I want to buy more)

I rate these stocks as top options for dividend income.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »